Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Titel:
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Auteur:
Waddell, Tom Chau, Ian Cunningham, David Gonzalez, David Okines, Alicia Frances Clare Wotherspoon, Andrew Saffery, Claire Middleton, Gary Wadsley, Jonathan Ferry, David Mansoor, Wasat Crosby, Tom Coxon, Fareeda Smith, David Waters, Justin Iveson, Timothy Falk, Stephen Slater, Sarah Peckitt, Clare Barbachano, Yolanda